SK Capital Partners

SK Capital Partners is a private equity firm established in 2007 and headquartered in New York, with an additional office in Boca Raton, Florida. The firm specializes in investing in mature and middle-market companies, focusing on sectors such as specialty materials, chemicals, healthcare, and pharmaceuticals. SK Capital Partners engages in various investment strategies, including recapitalizations, buyouts, growth equity investments, and corporate spinouts, often partnering with family-owned businesses and entrepreneurs. The firm typically invests between $100 million and $200 million in companies with revenues ranging from $50 million to $1 billion and prefers to take majority stakes. Its investment areas within specialty materials include personal care ingredients, agrochemicals, and construction materials, while its healthcare focus encompasses pharmaceuticals, medical devices, and healthcare services. With a strong emphasis on transformational value creation, SK Capital Partners leverages the extensive industry and operational expertise of its leadership team to drive growth in its portfolio companies, primarily targeting investments in North America.

Cole Abernathy

Vice President

Shawn Abrams

Director

Robert Abrams

Principal

Alex Alsop

Associate

Yawer Amin

Vice President

Michael Anagnos

Senior Associate

Natalie Blosser

Senior Associate

Jonathan H. Borell

Managing Director

Mckenzie Chu

Senior Associate

Aaron Davenport

Managing Director and Executive Committee Member

Ben Dillon

Managing Director

Simon Dowker

Managing Director

Booey Ghani

Vice President

Harman Gill

Associate

Jack Van Hulst

Operating Partner

Richard Jackson

Managing Director and Head of Capital Markets

Alexander Jackson

Associate

Jamshid Keynejad

Founder, Managing Director and Managing Director and Executive Committee Member

Jared Kramer

Principal

Joshua Landsberg

Associate

Josh Lieberman

Principal

Dan Lory

Principal

James Marden

Managing Director

Anthony Marr

Senior Associate

Julius O. Nestler

Senior Associate

Santiago Nielsen

Vice President

Jack Norris

Managing Director and Executive Committee Member

Christina Park

Associate

Dante Parrini

Senior Director

Barry Penney

Managing Director

Sanjeet Raman

Senior Associate

Barry Siadat Ph.D

Managing Director and Executive Committee Member

Scott Solomon

Senior Associate

Andrew Tabatabaei

Associate

Huai-Ming Xu

Associate

22 past transactions

Valentus Specialty Chemicals

Acquisition in 2021
Valentus Specialty Chemicals is a holding company focused on partnering with businesses with superior coatings technologies that can be applied in a broad range of niche end markets. Through strategic partnerships with market-leading businesses, Valentus seeks to build a specialty coatings company with a wide range of technological capabilities and a broad geographic reach. Valentus is focused on serving customers that are not targeted or effectively serviced by the industry’s largest players.

Canlak

Acquisition in 2021
Canlak specialize in the conception and manufacturing of high quality wood coatings ideal for the industry of wood flooring, kitchen cabiets, furniture an all wood surfaces.

Lacerta Group

Acquisition in 2021
Lacerta Group, Inc. is a leading provider of innovative thermoformed packaging solutions. The Company has built its reputation based on product integrity, excellent customer service, and above all, speed to market. Lacerta offers a comprehensive product portfolio and in-house design capabilities, with a customer-centric business model focused on tailored solutions for food processors and supermarkets. The Company’s fully integrated manufacturing platform includes capabilities across the product lifecycle in design & engineering, prototyping, mold-making & tooling, thermoforming, extrusion, and printing.

Lacerta Group

Venture Round in 2021
Lacerta Group, Inc. is a leading provider of innovative thermoformed packaging solutions. The Company has built its reputation based on product integrity, excellent customer service, and above all, speed to market. Lacerta offers a comprehensive product portfolio and in-house design capabilities, with a customer-centric business model focused on tailored solutions for food processors and supermarkets. The Company’s fully integrated manufacturing platform includes capabilities across the product lifecycle in design & engineering, prototyping, mold-making & tooling, thermoforming, extrusion, and printing.

Tilley Distribution

Acquisition in 2021
Tilley Distribution is a value-added distributor specializing in specialty chemicals and lubricants across various markets, including food and beverage, personal care, and lubricants. The company operates modern distribution facilities and maintains a substantial fleet of transportation equipment to meet the chemical needs of its customers. Tilley aims to serve as an extension of its suppliers' selling networks, enhancing partnerships to reach broader customer bases effectively. In addition to distribution, Tilley offers custom blending, packaging services, and research and development lab services, enabling clients to create tailored supply chain solutions that cater to their unique business requirements.

Catalent - Blow-Fill-Seal Sterile Contract Development and Manufacturing Business

Acquisition in 2021
Blow-Fill-Seal Sterile CDMO Business is focusing on complex clinical to commercial-stage formulation and manufacturing. The Business supports a global, blue-chip customer base with a broad array of products that leverage its BFS sterile manufacturing capabilities and formulation competency in complex chemistries including small molecule, biologics, macromolecules, and potent compounds.

Purisys

Seed Round in 2021
Purisys specializes in the development and manufacture of cannabinoid ingredients, particularly focusing on CBD and other cannabinoid-based compounds for pharmaceutical applications. The company serves a diverse range of markets, including pharmaceuticals, personal care, food and beverage, and nutritional supplements, allowing clients to create products aimed at treating, curing, or preventing diseases. Their main facility in Athens, GA, spans 17,000 square feet and is equipped with extensive experience in complex synthetic chemistry. Purisys also possesses significant expertise in controlled substances, enhancing its capabilities in the production of pharmaceutical active pharmaceutical ingredients (APIs) and supporting various chemical synthesis projects.

Ipackchem

Acquisition in 2020
Ipackchem was created in 1987 by Jean-Philippe Morvan as a division of Air Products Group and is a leading global manufacturer of barrier packaging. Its products are mainly used in the transport and storage of aromas, fragrances and agrochemical products, for which permeability, contamination and evaporation constraints are critical.

Venator Materials

Post in 2020
Venator Materials is a global chemical company dedicated to the development and manufacture of titanium dioxide (TiO2) pigments and performance additives. At Venator they are focused on delivering pigments and additives that make a difference to daily life and contribute to a more sustainable future. Their broad and versatile portfolio of leading pigments and additives includes many well-known brand names and industry-leading products.

NuCera Solutions

Acquisition in 2020
NuCera is a global leader in the development and manufacture of highly differentiated specialty polymers for markets that require high quality and performance: Adhesives, Candles, Coatings, Imaging, Masterbatches, Personal Care and Plastics. NuCera supplies performance chemistry to global markets from its highly flexible manufacturing facilities in Barnsdall, OK.

Techmer PM

Acquisition in 2020
Techmer PM, LLC is a manufacturer of colors and additives tailored for the plastics and fiber industries. The company offers a diverse range of additives, including antistats, flame retardants, heat stabilizers, and various custom color masterbatches that feature effects such as marble and swirl, thermo chromatics, and phosphorescents. Its products cater to multiple processing methods, including injection molding, blown film, and extrusion, making them suitable for a wide array of applications in sectors such as agriculture, automotive, construction, electronic packaging, and personal care. Established in 1981 and headquartered in Clinton, Tennessee, Techmer PM also specializes in biopolymer additives and has formed a strategic partnership with SK Capital Partners to enhance its market presence.

GEON Performance Solutions

Acquisition in 2019
GEON Performance Solutions serves customers in a wide variety of sectors, including appliances, building & construction, electronics, healthcare, transportation, and wire and cable.

Perimeter Solutions

Acquisition in 2017
Perimeter Solutions is a global manufacturer specializing in firefighting products and lubricant additives, operating in two main segments: Fire Safety and Specialty Products. The Fire Safety division formulates and produces fire management chemicals, positioning the company as a leader in this sector. The Specialty Products segment focuses on high-quality phosphorus pentasulfide, which is essential for ZDDP-based lubricant additives that enhance engine performance and longevity, in addition to applications in pesticides and mining chemicals. While the company has a worldwide presence, it generates the majority of its revenue from the United States.

Archroma

Private Equity Round in 2017
Archroma is a global color and specialty chemicals company based in Reinach, Switzerland, employing approximately 3,000 people across 35 countries and operating 24 production sites. The company focuses on three main business areas: Brand & Performance Textile Specialties, Packaging & Paper Specialties, and Coatings, Adhesives & Sealants. Archroma provides specialized performance and color solutions tailored to meet local market needs, enhancing everyday life while prioritizing environmental sustainability. The company is dedicated to innovation and quality, striving to improve industry standards and practices through its commitment to sustainable development.

Wavelength Pharmaceuticals

Acquisition in 2017
Perrigo API is a leading developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel and supporting functions in the U.S. and India. The Business has a global customer base and a broad array of products that leverage its specialized manufacturing capabilities and core competency in complex chemistries. Perrigo API is known for its uncompromising commitment to the highest quality and reliability standards and has an exemplary compliance track record.

Tri-Tex

Acquisition in 2017
Tri-Tex is a producer of high-performance specialty chemicals focused on the adhesive, sealants, surfactants and textile & paper chemical markets. Headquartered in St-Eustache, Quebec, Tri-Tex’s comprehensive suite of products are critical precursors used to develop every-day consumer and industrial applications in a variety of end-markets including paints, printing, personal care, hygiene, construction, textile and marine.

D.B. Western

Acquisition in 2017
D.B. Western, a technology-driven producer of formaldehyde and derivatives. The company’s La Porte, Texas, plant is the merchant market plant in North America serving a variety of applications including oilfield, refineries and petrochemicals.

Niacet

Acquisition in 2017
Niacet is a prominent manufacturer of organic salts, specializing in propionates and acetates, which are crucial for extending the shelf life of food and pharmaceutical products. Operating two fully automated production facilities in Niagara Falls, New York, and Tiel, The Netherlands, Niacet ensures high-quality output for a diverse global market. Its products play an essential role in various applications, including food preservation, antibiotic formulation, dialysis treatment, and energy production, addressing vital needs in everyday life across the food, pharmaceutical, and technical industries.

Tasmanian Alkaloids

Acquisition in 2016
Tasmanian Alkaloids Pty Ltd. is a manufacturer of controlled substances, specializing in the production of medicinal opiates derived from patented poppy varieties cultivated in Tasmania. Founded in 1975 and based in Westbury, Australia, the company offers agricultural services as well as chemical and analytical research and development. Its products are primarily used in pharmaceuticals and are distributed through a global network of distributors and agents. Tasmanian Alkaloids emphasizes high-quality standards and good manufacturing practices to ensure a reliable supply for its long-term business partners.

AEB Group

Acquisition in 2015
AEB Group, headquartered near Brescia, Italy, specializes in the research and production of biotechnologies and additives for the food and beverage industry. Founded in 1963, the company manufactures a wide range of products, including fermentation agents, clarifiers, stabilizers, filter aids, and cleaning solutions tailored for sectors such as winemaking, brewing, and fruit processing. AEB Group also provides hygiene and maintenance products for food production equipment, as well as systems for air and environmental treatment. Its extensive portfolio includes yeast extracts, enzyme cultures, and various sanitation treatments, primarily serving professional and agroalimentary applications. The company operates multiple production facilities across Italy, Spain, Portugal, France, Brazil, Argentina, and South Africa, distributing its products through a network of distributors and representatives both domestically and internationally.

Halo Pharmaceutical

Private Equity Round in 2015
Halo Pharmaceutical, located in Whippany, New Jersey, specializes in contract dosage form development, manufacturing, and testing services for the pharmaceutical, biotechnology, and generic sectors. The company provides a comprehensive range of services that include the development and production of various dosage forms, such as tablets, capsules, powders, liquids, creams, and both sterile and nonsterile ointments and suppositories. By focusing on integrated capabilities, Halo Pharmaceutical aims to support its clients in advancing their products and ultimately improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.